BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13130506)

  • 1. Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells.
    Zhu CJ; Li YB; Wong MC
    J Neurosci Res; 2003 Oct; 74(1):60-6. PubMed ID: 13130506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
    Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
    Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
    J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
    Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2001 Aug; 7(8):2537-44. PubMed ID: 11489837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).
    Frankel A; Rosen K; Filmus J; Kerbel RS
    Cancer Res; 2001 Jun; 61(12):4837-41. PubMed ID: 11406560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
    Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.
    Benimetskaya L; Ayyanar K; Kornblum N; Castanotto D; Rossi J; Wu S; Lai J; Brown BD; Popova N; Miller P; McMicken H; Chen Y; Stein CA
    Clin Cancer Res; 2006 Aug; 12(16):4940-8. PubMed ID: 16914583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A; Agrawal KC
    Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
    Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
    You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
    Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
    Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells.
    Chu S; Yuan X; Li Z; Jiang P; Zhang J
    Surg Neurol; 2006 Jun; 65(6):533-8; discussion 538. PubMed ID: 16720163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
    Rudin CM; Yang Z; Schumaker LM; VanderWeele DJ; Newkirk K; Egorin MJ; Zuhowski EG; Cullen KJ
    Cancer Res; 2003 Jan; 63(2):312-8. PubMed ID: 12543781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase levels and altered CpG methylation in the total genome and in the GSTP1 gene in human glioma cells transfected with sense and antisense DNA methyltransferase cDNA.
    Antoun G; Baylin SB; Ali-Osman F
    J Cell Biochem; 2000 Apr; 77(3):372-81. PubMed ID: 10760946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
    Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
    Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
    Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
    Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.